TANDEM TRANSPLANT FOR OVARIAN CANCER

Project Details

Description

Determine the maximal tolerated dose (MTD) of topotecan combined with fixed dose of etoposide as a component of multi-cycle high dose chemotherapy (HDC) regimen supported by peripheral blood progenitor cells. To evaluate the response, time to progression, disease free survival and overall survival of ovarian cancer patients with persistent, refactory, or recurrent disease, treated with multi-cycle HDC consisting of sequential combinations of pacitaxel, carboplatin, topotecan, etoposide and thiotepa.
StatusFinished
Effective start/end date1/10/9730/09/99

Funding

  • National Center for Research Resources

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.